Stock screenerAll disclosures →
EDGAR →
QUCY
Conviction 57HealthcareScan · Mon, Aug 10, 2026QUCY$1.39-3.82%
ResistanceSupportVol 14Vol MA14 655.92K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price1.39
Change-3.82%
Gap-1.04%
Rel volume0.27×
Avg volume695.95K
Avg $ vol878.02K
SMA 201.22
SMA 501.56
SMA 200—
Price vs 50-11.26%
Price vs 200—
MA stack—
50/200 cross—
Supertrendup · 1.08
RSI (14)52
MACD hist0.06
MACD crossbull · 9d
Stoch %K / %D68 / 71
ADX (14)17
+DI / −DI31 / 18
RSI divergence—
MACD divergenceBullish
ATR %+10.21%
ADR %8.08%
52w high3.56
52w low0.3228
From 52w high-61.10%
Above 52w low+329.06%
New 52w highNo
SqueezeOff
Bollinger width43.69%
%B0.80
Donchian pos68.27%
Donchian high1.55
Donchian low1.03
AVWAP (52w high)2.79
vs AVWAP high-50.38%
AVWAP (52w low)2.08
vs AVWAP low-33.38%
OBV trendFlat
Chaikin MF (20)0.12
Today vs 20d0.27×
Avg vol (14d)655.92K
Avg vol (20d)695.95K
Avg $ vol (20d)878.02K
Market cap20.31M
RS 3m (vs SPY)+285.50%
RS 6m (vs SPY)—
RS line new highNo
Trend template—
Technical rank43.6
1 week+9.92%
1 month+1.84%
3 months+281.12%
6 months—
1 year—
YTD+82.62%
P/E-1.25
P/B4.42
P/S37.81
P/FCF-1.85
EPS-2.70
Div yield—
ROE-353.23%
ROA-210.04%
Debt/Eq0.21
Current2.11
EV/EBITDA-1.07
Gross margin72.58%
Net margin—
Rev growth-39.92%
EPS growth24.95%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value16.56M
Revenue—
Net income-5.08M
Gross profit—
Free cash flow-10.98M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out22.77M
Employees13
ListedFri, Nov 5, 2021
Free float11.37M
Float %90.8%
Short interest2.81M
Days to cover2.7d
Short volume59.5%
Squeeze score67 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction57 / 100
Pattern quality—
Tech rank43.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.74
Support1.16
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in QUCY
No recent disclosed trades by Congress in QUCY. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in QUCY · 6 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Lazar David E. Chief Executive Officer · Ordinary Shares · 2026-08-05 | Convert | 9M | $81M | 2026-08-05 | 2026-08-07 |
Lazar David E. Chief Executive Officer · Series B Preferred Shares · 2026-08-05 | Convert | 1M | — | 2026-08-05 | 2026-08-07 |
Lazar David E. Chief Executive Officer · Series D Preferred Shares · 2026-08-05 | Convert | 124.7K | — | 2026-08-05 | 2026-08-07 |
Lazar David E. Chief Executive Officer · Ordinary Shares · 2026-08-05 | Convert | 28.06M | $6313M | 2026-08-05 | 2026-08-07 |
Lazar David E. Chief Executive Officer · Series A Preferred Shares · 2026-08-05 | Convert | 1M | — | 2026-08-05 | 2026-08-07 |
Lazar David E. Chief Executive Officer · Series C Preferred Shares · 2026-08-05 | Convert | 1M | — | 2026-08-05 | 2026-08-07 |
Ben-Tzvi Avraham Director · Ordinary Shares · 2026-07-31 | Grant | 112.26K | — | 2026-07-31 | 2026-08-05 |
O'Rourke Peter Director · Stock Option (Right to Buy) · 2026-07-06 | Grant | 112.86K | — | 2026-07-06 | 2026-07-07 |
Ben-Tzvi Avraham Director · Ordinary Shares · 2026-05-08 | Grant | 137.14K | $0 | 2026-05-08 | 2026-05-26 |
NATAN DAVID Director · Ordinary Shares · 2026-05-08 | Grant | 137.14K | $0 | 2026-05-08 | 2026-05-21 |
SEC filings
EDGAR filings in QUCY · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.